CX3CR1 and myocardial infarction: These clinical associations have led to animal studies together with our collaborators at Kancera, which show in the rat MI model that CX3CR1 inhibition prior to reperfusion limits infarct size by 50%, and reduces neutrophil influx, oedema, and finally IMH (unpublished data [68]).